& Masterworks
Good day, 360! Here are some of our top movers today.
And look out for a special invitation to join Jason Bond tonight at 8pm EST for 7 Secrets to Grow a $2,000 Account. He’s been killing it for over a YEAR so you need to learn his strategy for growing a small account —> tonight 8pm HERE.
FOCUS LIST🔎
NIVF – Up over 90% in the pre-market after announcing this it had signed binding term sheet for reverse merger with European Wellness Investment Holdings
CADL – Up over 120% in pre after announcing CAN-2409 achieved primary endpoint in Phase 3 Prostate Cancer Trial, showing significantly improved disease-free survival
MIND – Up over 14% in pre after reporting better than expected Q3 financial results
*sponsored by Masterworks
Over the last seven elections, this asset class has outpaced the S&P 500
Instead of trying to predict which party will win, and where to invest afterwards, why not invest in an ‘election-proof’ alternative asset? The sector is currently in a softer cycle, but over the last seven elections (1995-2023) blue-chip contemporary art has outpaced the S&P 500 by 64% even despite the recent dip, regardless of the victors, and we have conviction it will rebound to these levels long-term.
Now, thanks to Masterworks’ art investing platform, you can easily diversify into this asset class without needing millions or art expertise, alongside 65,000+ other art investors. From their 23 exits so far, Masterworks investors have realized representative annualized net returns like +17.6%, +17.8%, and +21.5% (among assets held longer than one year), even despite a recent dip in the art market.*
Past performance not indicative of future returns. Investing Involves Risk. See Important Disclosures at masterworks.com/cd.
HOTLIST🔥
NIVF – Up over 90% in the pre-market after announcing this it had signed binding term sheet for reverse merger with European Wellness Investment Holdings
NewGenIvf Group Ltd (NIVF) is an assisted reproductive services (ARS) provider helping couples and individuals obtain access to fertility treatments based in the United States.
In the pre-market this morning, the company announced that it has entered into a binding term sheet regarding the previously announced proposed reverse merger with healthcare company European Wellness Investment Holdings Limited (EWIHL).
Highlights of the transaction include:
Pursuant to the Term Sheet, it is proposed that NewGen issue 141,250,000 of its ordinary shares to the shareholder(s) of EWIHL or its associate in exchange for 100% equity interest of EWIHL, at a deemed price per share of US$3.20, representing an aggregate amount of US$452,000,000.
Following completion of the Proposed Transaction, EWIHL Shareholders are expected to hold approximately 61.6% equity interest in NewGen.
Increased market capitalization and visibility will support NewGen’s continued listing on the Nasdaq Global Market
Proposed transaction holds significant potential for synergistic value creation
Shares of NIVF traded up over 90% in the pre-market in reaction to the news.
The $0.56 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $0.6269, $0.70, $0.80, $0.86, $0.90, $1 and then the pre-market high at $1.03.
Below $0.56 targets to the downside are $0.50 and then a gap fill at $0.3910.
CADL – Up over 120% in pre after announcing CAN-2409 achieved primary endpoint in Phase 3 Prostate Cancer Trial, showing significantly improved disease-free survival
Candel Therapeutics Inc. (CADL) is a clinical stage biopharmaceutical company that engages in the development of immunotherapies for cancer patients.
In the pre-market this morning, the company announced results from a multicenter phase 3 clinical trial evaluating CAN-2409 viral immunotherapy in localized prostate cancer patients.
Highlights include:
Positive topline data for CAN-2409 viral immunotherapy achieved primary endpoint by demonstrating statistically significant and clinically meaningful benefit when combined with radiation therapy for intermediate-to-high risk, localized prostate cancer
The safety profile of CAN-2409 was generally consistent with previous studies, with no new safety signals identified
The phase 3 clinical trial was conducted under a Special Protocol Assessment (SPA) with the FDA
Shares of CADL traded up over 180% in the pre-market in reaction to the news.
The $9.90 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $11, $11.25, $12.70 and then the pre-market high at $14.02.
Below $9.90, targets to the downside are $9.57, $8.50, $7.50, $6, $5.50 and then a gap fill at $4.61.
*sponsored by Klondike Royalties
Is oil and gas missing from your portfolio?
With Klondike Royalties, you could gain from established oil and gas assets. Each royalty offers potential returns from real production, managed by deeply experienced operators. Add a piece of the energy sector to your portfolio.
MIND – Up over 14% in pre after reporting better than expected Q3 financial results
MIND Technology Inc. (MIND) together with its subsidiaries, provides technology to the oceanographic, hydrographic, defense, seismic, and maritime security industries worldwide.
In the after hours yesterday, the company announcedfinancial results for its fiscal 2025 third quarter ended October 31, 2024.
Highlights Include:
Revenues from continuing operations for the third quarter of fiscal 2025 were approximately $12.1 million compared to approximately $5.0 million in the third quarter of fiscal 2024.
Net income for the third quarter of fiscal 2025 amounted to $1.3 million compared to $568,000 in the third quarter of fiscal 2024. Third quarter of fiscal 2025 net income attributable to common shareholders (after the effect of the conversion of preferred stock into common stock) was $15.7 million, or $2.87 per share compared to a loss of $379,000, or a loss of $0.27 per share in the third quarter last year.
The backlog of Marine Technology Products related to Seamap segment as of October 31, 2024 was approximately $26.2 million which was flat sequentially compared to backlog as of July 31, 2024.
Rob Capps, MIND’s President and Chief Executive Officer, stated,
“We are very pleased to report that third quarter revenue grew 21% sequentially and 143% over last year’s third quarter…As in the second quarter, we generated positive cash flow from operations in this quarter, increasing our cash balance to $3.5 million as of October 31, 2024.”
Shares of MIND traded up over 14% in the pre-market in reaction to the news.
The $4.76 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $5, $5.20, $5.40, $5.60 and then the after-hours high at $6.10.
Below $4.76, targets to the downside are $4.60 and then a gap fill at $4.23.
MARKET NEWS 📰
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
